<DOC>
	<DOC>NCT00549068</DOC>
	<brief_summary>To compare the subject satisfaction rating in women treated for postmenopausal osteoporosis with Actonel 35mg Once-a-Week for 24 weeks, and receiving feedback information, after 12 weeks of treatment, based on bone resorption marker results using the NTx Point-Of-Care (POC) device, to similar women treated as per regular clinical practice</brief_summary>
	<brief_title>POWER Point of Care Effect on Satisfaction of Treatment</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis, Postmenopausal</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<criteria>Women diagnosed with postmenopausal osteoporosis using community practice standards Women previously nontreated for osteoporosis, OR treated for osteoporosis with biphosphonates (alendronate, etidronate), hormone replacement therapy estrogen, estrogenrelated drugs, progesterone, subcutaneous estrogen implant), raloxifene, fluoride, or calcitonin within the past 2 years but discontinued prior to enrolment into the study either due to:lack of effect or intolerance Subjects treated with Actonelr 5 mg daily, Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study Subject unlikely to comply with protocol, e.g., uncooperative attitude, inability to return for followup visits, and unlikelihood of completing the study Known/Suspected hypersensitivity to any component of Actonelr 35 mg OnceaWeek Known/Suspected hypocalcaemia Known/Suspected severe renal impairment (creatinine clearance &lt; 30ml/min) Known/Suspected hyperparathyroidism Known/Suspected hyperthyroidism Known/Suspected active urinary tract infection Known high urine levels of calcium (3 4mg/ml) The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>